Sivia Capital Partners LLC Makes New $1.82 Million Investment in Agilent Technologies, Inc. $A

Key Points

• Sivia Capital Partners initiated a $1.82 million position in Agilent Technologies, purchasing 13,689 shares during the second quarter. Several other major institutional investors also increased their holdings.
• Analysts maintain a favorable outlook, with a consensus rating of “Moderate Buy” and an average price target of $160.24. Morgan Stanley raised its target to $175, while Wells Fargo reduced its target to $160.
• Agilent reported quarterly EPS of $1.49 and revenue of $1.83 billion, exceeding analyst estimates, with revenue up 10% year over year. The company also pays a quarterly dividend of $0.255 per share, representing a 0.7% yield.

Sivia Capital Partners LLC bought a new position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 13,689 shares of the medical research company's stock, valued at approximately $1,818,000.

A number of other hedge funds have also modified their holdings of A. State Street Corp lifted its stake in shares of Agilent Technologies by 1.9% in the fourth quarter. State Street Corp now owns 12,681,792 shares of the medical research company's stock worth $1,725,611,000 after buying an additional 241,029 shares in the last quarter. Geode Capital Management LLC grew its stake in Agilent Technologies by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company's stock valued at $1,006,519,000 after acquiring an additional 25,139 shares in the last quarter. Morgan Stanley grew its stake in Agilent Technologies by 15.9% during the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company's stock valued at $686,049,000 after acquiring an additional 692,202 shares in the last quarter. Norges Bank acquired a new stake in Agilent Technologies in the 4th quarter valued at about $549,158,000. Finally, Cantillon Capital Management LLC lifted its stake in Agilent Technologies by 0.8% in the 4th quarter. Cantillon Capital Management LLC now owns 3,115,638 shares of the medical research company's stock worth $423,945,000 after purchasing an additional 23,493 shares in the last quarter.

Analyst Ratings Changes

Several research analysts have recently weighed in on the company. Wells Fargo & Company lowered their target price on Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating on the stock in a report on Thursday, May 28th. Sanford C. Bernstein began coverage on Agilent Technologies in a report on Friday, June 26th. They issued an "outperform" rating and a $155.00 price target for the company. Wall Street Zen upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Sunday, August 2nd. Morgan Stanley boosted their price objective on Agilent Technologies from $160.00 to $175.00 and gave the stock an "overweight" rating in a research note on Wednesday. Finally, Royal Bank Of Canada began coverage on Agilent Technologies in a report on Wednesday, May 27th. They issued an "outperform" rating and a $153.00 target price for the company. Two analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $160.24.

Agilent Technologies Stock Performance

NYSE:A opened at $149.33 on Friday. The company's 50-day moving average is $135.12 and its two-hundred day moving average is $125.40. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $160.27. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The firm has a market capitalization of $42.18 billion, a price-to-earnings ratio of 29.99, a PEG ratio of 2.62 and a beta of 1.25.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.41 by $0.08. The business had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business's revenue was up 10.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts forecast that Agilent Technologies, Inc. will post 6.03 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were paid a dividend of $0.255 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 annualized dividend and a yield of 0.7%. Agilent Technologies's dividend payout ratio (DPR) is 20.48%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source